Plasma lipid composition.

<p>SFA (Saturated Fatty Acids), MUFAs (Mono-Unsaturated Fatty Acids) and PUFAs (Poly-Unsaturated Fatty Acids) were measured by gas-liquid chromatography in plasma of fasted mice after 10 weeks feeding with ND (black column, n = 6), HFD (white column, n = 12) or HFD+EPA (grey column, n = 9). Data are expressed as mean ±SEM. *p<0.05, **p<0.01, ***p<0.001 vs ND; # p<0.05, ## p<0.01, ### p<0.001 vs HFD. ns: not significant</p

Effect of EPA on muscle lipid metabolism.

<p>(A) Intramuscular triglycerides content in red gastrocnemius of ND (n = 9), HFD (n = 10) and HFD+EPA (n = 10) mice. (B) ¹⁴C-palmitate complete β-oxidation and mRNA expression of (C) CPT1b and (D) UCP3 in soleus muscle of ND (n = 9), HFD (n = 6–10) and HFD+EPA mice (n = 6–10). Results are mean ±SEM and were normalized to the ND group (100%) for B, C and D, *p<0.05, **p<0.01, ***p<0.001</p

Protective effect of EPA supplementation on the HFD-induced obesity.

<p>(A) Body weight in mice after 10-week feeding with a ND (n = 12), HFD (n = 14) or HFD+EPA(n = 14). Results represent mean ±SEM. *p<0.05, **p<0.01, ***p<0.001 vs ND; and ### p<0.001 vs HFD, ns: not significant. (B) fat and lean mass and (C) fat pads weights of subcutaneous (Subcut), perigonadal (Perigon) and mesenteric (Mes) adipose tissue in mice fed for 10 weeks with a ND or N (n = 12), HFD or H (n = 14) or HFD+EPA or E (n = 14) Results represent mean ±SEM. ***p<0.001, (D) Representative photographs of H&E staining of liver section of mice fed the different diets for 10 weeks (bar = 200 µm).</p

Protective effect of EPA supplementation on the HFD-induced impaired glucose metabolism.

<p>(A) Glycemia and (B) insulinemia in 6 h-fasted mice fed a ND (n = 12), a HFD (n = 14) or a HFD+EPA (n = 14) after 10 weeks. Results represent mean ±SEM. ***p<0.001, (C) OGTT curves and area under the curve (AUC) of glycemia monitored during OGTT performed on 6 h fasted (during light period) mice after 9 weeks of diet in ND (n = 4), HFD (n = 6) and HFD+EPA (n = 6) mice. Results represent mean ±SEM. *p<0.05, **p<0.01, ***p<0.001 vs ND; and ## p<0.01, ### p<0.001 vs HFD.</p

EPA induces in vivo and in vitro expression of the apelin/APJ system in muscle.

<p>(A) Apelin and (B) APJ mRNA expression in soleus muscle of ND (n = 7), HFD (n = 10) and HFD+EPA (n = 5). Results represent mean ±SEM **p<0.01, ***p<0.001, ns: not significant. (C) Apelin mRNA expression and (D) secretion in differentiated C2C12 cells treated with the indicated EPA concentrations or the corresponding BSA content for 24 hours after 12-hour serum deprivation. Data are mean ±SEM n = 4–5 in each condition. *p<0.05, **p<0.01 ***p<0.001. (E) Effect of 100 µM EPA in the absence or in the presence of the PI3K inhibitor LY294002 (20 µM) or the ERK 1/2 inhibitor U0126 (20 µM) for 24 h after 12-hour serum deprivation on apelin mRNA expression and (F) secretion in differentiated C2C12 cells. Results represent mean ±SEM (n = 4–5 in each condition) *p<0.05, **p<0.01, ns: not significant.</p

Effect of EPA on adipokines and APJ mRNA expression in adipose tissue.

<p>(A) Leptin, (B) Adiponectin, (C) Apelin and (D) APJ expression in total adipose tissue of ND (n = 12), HFD (n = 14) and HFD+EPA mice (n = 14). Results represent mean ±SEM **p<0.01, ***p<0.001</p